Title and Organization:
Anthony Johnson, MBA, is the co-founder and CEO of Kodikaz Therapeutics Solutions Inc., an early stage non-viral gene therapy company in the oncology area. Kodikaz is commercializing an innovative technology that permits highly targeted therapeutic delivery to cancer cells and overcomes critical limitations of other gene therapies. Anthony is also a founding partner of Buffalo Biosciences, a life science strategic management services firm, where he consults on healthcare IT, medical devices, gene therapy, and drug discovery. Prior to founding Kodikaz, Anthony was the president and CEO of Empire Genomics, a leading molecular diagnostic firm specializing in the delivery of precision medicine in the oncology arena. Serving as the firm's founding CEO, Anthony took the business through multiple funding rounds, signed numerous licensing and international distribution deals, and initiated clinical development of companion diagnostics with biotech partners in the areas of multiple myeloma and prostate cancer. Previously, Anthony worked for Invitrogen Corporation, where he created and led the firm’s stem cell and regenerative medicine franchise. Anthony serves on several boards, including WNED/PBS Western New York, and is the secretary of the Board of Trustees of Paul Smith’s College. He is also a founding board member of the Communities of Giving Legacy Initiative, which works to create positive change in the lives of low-income youth of color via access to people, places, and experiences that help them achieve their life goals. He is a mentor to numerous technology startups and a volunteer with the Big Brother Big Sister organization. He earned an MBA from the Alliance Manchester Business School in Manchester, England, and a bachelor's degree in biology from Fisk University in Nashville, Tennessee. Anthony is a Fellow of the second class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.